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This case report details the multidisciplinary treatment of  peripartum left iliac vein 
thrombosis using percutaneous catheter-dlrected urokinase thrombolysis and balloon 
thromboplasty. Enhanced chances for long-term patency and the normalization of  venous 
fimction make these minimally invasive procedures accepted options for the treatment of  
iliofemoral deep venous thrombosis in selected peripartmn patients. (J Vasc Surg 1996; 
24:1030-3.) 
In  the last 5 years there have been changes in the 
approach to acute iliofemoral venous occlusion. Per- 
cutaneous catheter-based technology now allows vas- 
cular interventionalists o define and treat deep ve- 
nous thrombosis (DVT) with direct intravenous 
infusion of  thrombolytic agents. 
The ultimate goal in the treatment ofi l iofemoral 
DVT is to provide unobstructed venous drainage 
from the affected limb and to minimize the long-term 
sequelae of  venous hypertension and the develop- 
ment o f  the postthrombotic syndrome. Comerota ~
has delineated an algorithm for the aggressive man- 
agement o fDVT.  His work illustrates the success that 
can be obtained with a multidisciplinary approach 
that incorporates both thrombolytic therapy and sur- 
gical intervention. To our lmowledge, thrombolysis 
has not  been reported for the treatment o f  DVT in 
peripartum patients because its use has been thought  
to be contraindicated due to the potential for uncon- 
trolled bleeding. 
CASE REPORT 
A 30-year-old gravid woman at 38 weeks gestation with 
twins sought medical attention at Pennsylvania Hospital for 
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massive left lower extremity edema and pain of 72 hours 
duration. She had no history of DVT or of lower extremity 
edema. A work-up for a hypercoagulable state was not 
initially performed because systemic hepafin was adminis- 
trated on presentation to the emergency department. A 
color duplex ultrasonographic s an of the veins showed 
wide patency of the common femoral, superficial femoral, 
popliteal, and tibial veins. The left iliac vein was obscured 
by fetal cranium, but obstruction was suggested by a loss of 
phasicity of the Doppler signal at the common femoral 
level. 
With the presumptive diagnosis of acute iliac vein ob- 
struction, the patient was maintained on intravenous hep- 
arin. Heparin infusion was briefly suspended for induction 
of labor, and healthy twins were delivered vaginally. The 
heparin was resumed 12 hours after delivery at a dose to 
maintain the partial thromboplastin time at twice the con- 
trol level. 
Forty-eight hours after delivery, there was no improve- 
ment in the left lower extremity edema or pain. An ascend- 
ing venogram demonstrated complete occlusion of the left 
iliac vein with poor pelvic collateralization (Fig. i). 
A urokinase infusion (Abbokinase, Abbott Laborato- 
ries, North Chicago, Ill.) was elected. A 5F catheter was 
placed through the ipsilateral femoral vein. The clot was 
also entered through the contralateral-transcaval route with 
a guide wire~ which was exchanged for a 20-cm side-hole 
infusion catheter that spanned the thrombus. The uroki- 
nase infusion was initiated at 4000 units/kg/hr for 2 
hours, and was continued at 2000 nnits/kg/hr for 8 hours 
and thereafter at 1000 units/kg/hr. Early on in the treat- 
ment, 50 ml of bleeding from the cervical os was controlled 
with an infusion of Oxytocin (Wyeth-Ayerst Laboratories, 
Philadelphia, Pa.). Twelve hours after the initiation of 
therapy, a follow-up venogram showed recanalization of 
the vein; however, significant thrombus remained (Fig. 2). 
A second side-hole infusion catheter was placed through 
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Fig. 2. Ascending venogram 48 hours into urokinase in- 
fusion. 
Fig. 1. Ascending venogram 48 hours after delivery taken 
through a contralaterally placed infusion catheter manipu- 
lated through soft, completely occluding thrombus. 
the ipsilateral femoral vein, mid the urokinase infusion was 
maintained through both catheters at a total of 3000 
units/kg/hr fbr 8 hours. An additional 500.000 units of 
urokinase was pulse-sprayed over 20 minutes. 
The venogram showed three intraluminal defects (Fig. 
3), which were macerated with an8 mm× 4 cm balloon 
angioplasty catheter. The completion venograph now 
showed complete patency, and the uroldnase infusion was 
discontinued after a total of 6.6 million units over a 48- 
hour period (Fig. 4/. There was no clinical evidence of 
pulmonary embolism. 
Heparin therapy was continued and oral warfarin ther- 
apy was initiated. Within 24 hours, the patient had com- 
plete relief of her pain" and edema. She was discharged on 
the fourteenth day after delivery and continued taldng 
warfarin to maintain an i ternational normalized ratio of 
3.0. At 6 months after therapy, the patient remained with- 
out symptoms and had normal imb diameter without he 
use of compression stockings. A duplex study showed no 
evidence of clot, obstruction, or valvular eflux. The wmffa- 
fin therapy was discontinued. The patient has subsequently 
undergone t sting for a hypercoagulable state, the results of 
which were entirely normal. 
DISCUSSION 
The occurrence of  DVT m pregnant women is 
not an unusual event. The monthly incidence is be- 
tween 0.01 per thousand and 0.8 per thousand pa- 
tients during pregnancy, and 0.6 per thousand uring 
the postpartum period. 2~4 Pain and edema are the 
most common clinical findings. The ieff leg is more 
often affected than the right leg because of  compres- 
sion of  the left iliac vein by the right common iliac 
artery, s DVT is generally managed with intravenous 
heparin therapy before delivery Periparmm antico- 
agulation therapy is not without risks, and some 
investigators have recommended suprarenal vena ca- 
vai filter placement to  prevent pulmonary embolism 
in the immediate periparmm period. 6 
Heparin therapy for  DVT is effective in prevent- 
ing pulmonary emboli, but immediate, complete lysls 
occurs in only 4% of  patients, whereas 14:% have 
partial ysis; the remainder have no clearing of throm- 
bus7 Persistence o f  thrombus may lead to further 
stasis within the venous system and propagation of  
clot, and in some cases persistent thrombus will con- 
tribute to venous hypertension, s Direct involvement 
of  valves with clot, as welt as venous hypertension and 
dilatation of  the veins, leads to valvular incompe- 
tence, which is ultimately the cause of  the postthrom- 
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Fig. 3. Intraluminal filling defects before thromboplasty. 
Fig, 4. Completion venogram fter thromboplasty. Flattening at proximal left common iliac 
vein was an artifact. No constant deformity was noted by "wasting" of the angioplasty balloon. 
No fixed defects were present to suggest a "pelvic spur." Pull-through pressure gradient was zero. 
boric syndrome in most patients. 8,9 More recent 
long-term follow-up of patients who were recovering 
from acute DVT has shown that 10% of patients 
progress to have severe changes of  ulceration and the 
postthrombotic syndrome. 9 Although treatment of  
peripartum DVT has generally consisted of subcuta- 
neous end intravenous heparin anticoagulation with 
subsequent conversion to warfarin in the postpartum 
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period, the subsequent risk o f  the development o f  
postthrombotic omplications in these young pa- 
tients is a concern. Uroldnase infusion is contraindi- 
cated before delivery because o f  the risk o f  bleeding. 
The immediate postpartum state has been considered 
to contrahMicate thrombolytic therapy, as well, be- 
cause of  the risk o f  uterine bleeding. Our  patient did 
not have any significant bleeding and required no 
transfusions. 
The patient described received a total o f  6.6 mil- 
lion units o f  uroldnase over 48 hours, which is com- 
parable with other successful reports o f  iliofemoral 
thrombosis, z° Because of  the risk o f  bleeding, pa- 
tients should be monitored in the intensive care unit 
during the infusion ofthrombolyt ic  agents. Measure- 
ments o f  prothrombin time, partial thromboplastin 
time, fibrinogen, fibrin split products, and platelet 
count  should be performed every 4 hours, and the 
agent dose should be adjusted on the basis o f  these 
results. ~ ~ 
Residual thrombus is common after recanaliza- 
t ion in the venous system. Maceration of  a clot with 
angioplasty balloons has been successful in treating 
clotted dialysis access grafts, and this technique was 
extrapolated for  use with the small amount  o f  adher- 
ent iliac vein thrombus} 2,13 Thrombolyt ic therapy 
has been documented to accelerate the lysis o f  acute 
pulmonary emboli. It  is our feeling that mechanical 
disruption performed on clot well-laced with the 
thrombolytic agent  would allow for rapid in vivo 
clearance of  any thrombus mechanically fragmented 
in the pulmona W circulation. 
Some have suggested placement of  an inferior 
vena caval filter to prevent pulmonary embolism 
when clot extrudes into the inferior vena cava or 
when there is a long free-floating thrombus tail. 14,1s 
Others advocate their use only in patients who have 
established pulmonary embolii l° We were not faced 
with either ofthese problems. 
CONCLUSION 
We have demonstrated that  catheter-directed 
thrombolytic therapy in conjunction with balloon 
thromboplasty can be successfully used in postpar- 
tum patients for the treatment ofiliac venous throm- 
bosis. To our knowledge, this is the only report o f  
percutaneous catheter-directed therapy in this partic- 
ular patient population. 
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